Ahmed Hegazi is currently a Professor of Microbiology and Immunology in the National Research Center, Egypt. Prof. Hegazi received his master’s degree in 1979 and his PhD in 1981. His research work has been focused lately on bee products and their therapeutic effects. Dr. Hegazi awards; First Class Decoration of Excellence, Egypt, 1995, The Senior Scientist Prize of National Research Center, Cairo, Egypt, 1996, The National Scientific Prize In Biological Sciences, Egypt, 1990, The Scientific Prize of The National Research Center, Cairo, Egypt, 1989, The Second Best Research Paper Award, International Congress of Propolis, Bones Aires, Argentina, 2000, Main Speaker Award,10th Academic Conference, PRA and NAS (Nippon Apitherapy Soc.) Japan, 2006, 2 Bronze medals from The International Innovation Fair of the Middle East, Kuwait, 2007 Awarded of Ghazi Wad Allah Salon Prize, 2008. Awarded the Merit Aware of Medical Sciences, The National Research Center, 2016. Dr. Hegazi contributed Chairman of the National Committee for Microbiological Sciences (NCMS) in Egypt, Academy of Science and Technology, Egypt, from 2018. He organized and contributed to national and international research projects since 1977 and up till now; he has been the principal investigator on multiple research projects within the National Research Center. He Conducted training courses on Clinical Microbiology, National Research Center in 1979. He has 249 articles in national and international scientific journals. Editor in 48 journals, Referee in the 98 International Journals, Organizer of 196 International Symposium and conferences, 9 books in English language and 13 books in Arabic language. He has patent No. 28335at 11/12/2017. and registers for other 7.
Dr. Tülay Askin Celik is an Associate Professor of Biology Department of Faculty of Science, Adnan Menderes University. She have a masters in Biology from the University of Fırat, Elazığ, Turkey. She completed her PhD in Biology from the University of Fırat in 1997. She is a member of the European Association for Cancer Research (EACR) and Molecular Cancer Research Association (MOKAD). Current her scientific interests are bioactive phytochemicals and plant extracts on their functional role in cancer cells and in vitro/in vivo biological activities. Furthermore, she also investigating the genotoxic and cytotoxic effects of medicinal plant extracts, and environmental pollutants, and pesticides.
Kailash Chadha is the Emeritus Associate Member and Associate Professor of Oncology in the Department of Molecular and Cellular Biology at Roswell Park Cancer Institute, and in Department of Medicine, State University of New York at Buffalo, NY, USA. He got his Ph.D. degree in Virology from the University of Guelph, Guelph, Ontario, Canada. After his graduation he spent two years as a fellow of National Research Council of Canada. Following that he joined Roswell Park Cancer Institute in Buffalo, New York as a Cancer Research Scientist in the Department of Medical Viral Oncology. His research interests are in the area of cell and molecular biology of Herpes viruses, interferons and prostate cancer. He has published well over 125 publications, written several book chapters and currently holds six U.S. patents. He has been invited to participate in numerous national and international scientific meetings and has often chaired sessions on several international meetings. He is currently on the editorial board of several journals including Prostate Cancer J, International J Nephrology & Urology, Cancer & Clinical Research, J. Nephrology Research and member of several professional organizations including New York Academy of Sciences; American Association for the Advancement of Science; Society for Experimental Biology & Medicine; American Association for Cancer Research; International Society for Interferon & Cytokine research and The Society of Basic Urologic Research etc. He has edited a book on interferons entitled “Interferons: Current Status, published by Research Signpost (ISBN 81-7736-256-9). His immediate research interest is in developing new ”biomarkers” for early detection and management of prostate cancer and in studying physiological role of prostate-specific antigen (PSA) in regulating prostate tumor growth and in-particular role of PSA in “angiogenesis”. His research is being supported by National Cancer Institute, American Cancer Society, National Multiple Sclerosis Society, and EMD Serono Inc.